Immunophenotypic Evaluation of IL-7R α in Acute Leukaemia
Launched by RANIA ABDELTWAB ABDELAZEIM · Nov 30, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
Acute leukemia is generally understood to be a neoplastic process that exerts a maturational block at a hematopoietic precursor cell level, accompanied by a proliferative drive of varying degree. The resulting accumulation of cells, most frequently in the marrow, causes the typical clinical picture, which includes marrow failure, tissue infiltration, organomegaly and on occasion, tumor masses. AL is broadly classified as acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL) (1).
Acute lymphoblastic leukemia is frequently diagnosed in children and young adults, with incidence peaks...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Newly diagnosed patients with Acute leukemia (ALL, AML), male or female at any age.
- Exclusion Criteria:
- • Patients diagnosed with hematological malignancy other than acute leukemias
- • Patients receiving chemo and/or radiotherapy
- • Patients on steroid therapy for any other reason
- • Patients receiving any immunosuppressive drug
About Rania Abdeltwab Abdelazeim
Rania Abdeltwab Abdelazeim is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic approaches, she oversees the design, implementation, and management of clinical trials, ensuring compliance with regulatory standards and ethical guidelines. Her expertise in clinical research and collaboration with multidisciplinary teams facilitates the seamless execution of studies, aiming to contribute valuable insights to the medical community. Rania’s leadership is characterized by a patient-centered approach, fostering an environment of safety and integrity throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials